MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy-MedSci.cn

MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy

Wang, JC; Shang, Z; Wang, J; Xu, JH; Li, WG; Guan, YQ; Yang, L; Zhang, W; Shen, KF; Zhang, ML; Wang, J; Chen, LT; Li, QL; He, C; Wang, N; Huang, L; Xiao, Y; Xiao, M; Zhou, JF

Xiao, Y; Xiao, M (corresponding author), Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China.

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy

科室

工具

服务